« Back
Home /
HBX 41108

HBX 41108

Manufacturer	MedChem Express
Category	Inhibitors
Type	Inhibitors
Specific against	other
Amount	25mg
Item no.	HY-101666-25mg
CASRN	924296-39-9
Available
Product Description	HBX 41108 is an uncompetitive inhibitor of ubiquitin-specific protease 7 (USP7) with an IC50 of 424 nM. HBX 41108 inhibits USP7-mediated p53 deubiquitination to stabilize p53 and inhibits cancer cell growth. HBX 41108 induces p53-dependent apoptosis in p53 wild type and null isogenic cancer cell lines.
StorageTemperature	4°C, sealed storage, away from moisture; In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Applications	Cancer-programmed cell death
Formula	C13H3ClN4O
References	[1].Colland F, et al. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther. 2009 Aug; 8(8):2286-95. \| [2].Colombo M, et al. Synthesis and biological evaluation of 9-oxo-9H-indeno[1, 2-b]pyrazine-2, 3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes. ChemMedChem. 2010 Apr 6; 5(4):552-8.
MolecularWeight	266.64
Research Area	Cancer
Solubility	DMSO : 250 mg/mL (937.59 mM; ultrasonic and warming and heat to 60°C)
Target	Deubiquitinase; Apoptosis
Pathway	Cell Cycle/DNA Damage; Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25mg

available

Delivery expected until 4/13/2023

Compare

Add to wishlist

Recommend by mail

Request delivery time

Ask a technical question